ANGELA DIUBLE: Open Payments
NPI 1205872777 · TECUMSEH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 59 payments from 13 companies in 2025. Trend: 2023 $795 · 2024 $1,401 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $246 |
| AstraZeneca Pharmaceuticals LP | 8 | $186 |
| Axsome Therapeutics, Inc. | 5 | $140 |
| Galderma Laboratories, L.P. | 1 | $125 |
| PFIZER INC. | 5 | $113 |
| Novo Nordisk Inc | 5 | $102 |
| Lilly USA, LLC | 5 | $99 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Amgen Inc. | 2 | $34 |
Products named: Auvelity, VRAYLAR, REXULTI, AIRSUPRA, MOUNJARO, FARXIGA, Wegovy, PREVNAR 20.
Industry payments across MI — which companies pay providers there.
